In the context of lymph node metastasis, CXCL13-expressing exhausted CD8+ T-cells drive aggressive tumor phenotypes by enhancing interactions with tumor cells and activating ERK signaling pathways in tumor cells (223). Here, CXCL13 is linked to neoplasm.